IOGENETICS, LLC
11Patents
9Active
11Granted
47Portfolio score
Filing activity: Jan 23, 2004 → Jul 6, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10706955B2 | Bioinformatic processes for determination of peptide binding | Emerging Cross-Sectional Technologies | 11 | Active |
| US8394379B2 | Targeted cryptosporidium biocides | Chemistry; Metallurgy | 10 | Active |
| US7566447B2 | Biocides | Human Necessities | 4 | Expired |
| US8703134B2 | Targeted cryptosporidium biocides | Emerging Cross-Sectional Technologies | 2 | Active |
| US10799582B2 | Immunoglobulin polypeptide fractions from products of domestic animals | Chemistry; Metallurgy | 1 | Active |
| US11069427B2 | Mathematical processes for determination of peptidase cleavage | Physics | 1 | Active |
| US7300790B2 | Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins | Chemistry; Metallurgy | 0 | Expired |
| US12374421B2 | Bioinformatic processes for determination of peptide binding | Chemistry; Metallurgy | 0 | Active |
| US11640847B2 | Bioinformatic processes for determination of peptide binding | Emerging Cross-Sectional Technologies | 0 | Active |
| US11434259B2 | Modified Zika virus NS1 protein with reduced cross-reactive immunogenicity | Emerging Cross-Sectional Technologies | 0 | Active |
| US10755801B2 | Identifying peptides having T-cell-exposed motifs with known frequency of occurrence in a reference database | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.